Skip to main content

Table 2 Amplification in riskier strata of the testing set, following rank-ordering by predicted likelihood of Fabry disease

From: A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm

Risk group Amplification relative to total population Projected prevalence
Riskiest 10% 5.4× 1 in 9261
Riskiest 1% 23.9× 1 in 2090
Riskiest 0.1% 109.8× 1 in 455